Clinical TrialsSearch results
Number of results: 148
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma
- neuroblastoma
- Japan Neuroblastoma Study Group
- 2008-02-20
Other
- Japan Diabetes Outcome Intervention Trial 1(J-DOIT1) : Intervention study to prevent or delay type 2 diabetes mellitus
- Impaired Fasting Glucose
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2007-03-30
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)
- prostate cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Neoadjuvant and adjuvant chemotherapy with ifosfamide and adriamycin for adult high-grade soft tissue sarcomas in the extremities (JCOG0304, Neoadjuvant and adjuvant chemotherapy with IFO/ADM phase II)
- soft tissue sarcoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
- T2-T4aN0M0 invasive bladder cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Accelerated fractionation vs. conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study (JCOG0701)
- T1-2N0M0 glottic cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-05
Other
- A phase II study of stereotactic body radiation therapy in patients with T1N0M0 non-small cell lung cancer (JCOG0403)
- T1N0M0 non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study
- acute promyelocytic leukemia
- Japan Adult Leukemia Study Group (JALSG)
- 2005-09-13
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30